Prolonged infusion of gemcitabine in patients with platinum resistant or refractory recurrent ovarian carcinoma:: A phase II study Of GEICO (Spanish Group for investigation on ovarian cancer).

被引：0
|
作者：
Ojeda, B
Gonzaléz-Martín, A
Mellado, B
Bover, I
Fabregat, X
Rubio, MJ
Alonso, L
Lianes, P
Churruca, C
Poveda, A
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Hosp Ramon & Cajal, Madrid, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Sont Llatzer, Palma de Mallorca, Spain
[5] Hosp del Mar, Barcelona, Spain
[6] Hosp Reina Sofia, Cordoba, Spain
[7] Hosp Virgen Victoria, Malaga, Spain
[8] Hosp Mataro, Barcelona, Spain
[9] Hosp Donostia, San Sebastian, Spain
[10] IVO, Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：479S / 479S
页数：1
相关论文
共 50 条
  • [1] Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer
    Garcia, Agustin A.
    Yessaian, Anne
    Huyen Pham
    Facio, Grace
    Muderspach, Laila
    Roman, Lynda
    CANCER INVESTIGATION, 2012, 30 (04) : 295 - 299
  • [2] Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer
    Garcia, AA
    O'Meara, A
    Bahador, A
    Facio, G
    Jeffers, S
    Kim, DY
    Roman, L
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 493 - 498
  • [3] Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer
    D'Agostino, G
    Amant, F
    Berteloot, P
    Scambia, G
    Vergote, I
    GYNECOLOGIC ONCOLOGY, 2003, 88 (03) : 266 - 269
  • [4] RANDOMIZED PHASE II STUDY OF PACLITAXEL-CARBOPLATIN (PC) VERSUS GEMCITABINE-CARBOPLATIN (GC) FOLLOWED BY PACLITAXEL-CARBOPLATIN (PC) IN PLATINUM-SENSITIVE RECURRENT OVARIAN CARCINOMA (PSROC): A GEICO (SPANISH GROUP FOR INVESTIGATION IN OVARIAN CANCER) STUDY
    Martin, A. Gonzalez
    Casado, A.
    Arranz, J.
    Rubio, M. J.
    Calvo, E.
    Beltran, M.
    Mendiola, C.
    Sanchez, A.
    Santaballa, A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 307 - 307
  • [5] Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study
    Shen, Wenbin
    Jing, Chuyu
    Tian, Wenjuan
    Zhang, Wei
    Ren, Yulan
    Shan, Boer
    Wang, Huaying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (11) : 1764 - 1770
  • [6] Gemcitabine and Epirubicin in platinum-resistant or refractory advanced ovarian cancer patients: Preliminary results of a phase II study
    Arcuri, C.
    Sorio, R.
    Scalone, S.
    Caffo, O.
    Griso, C.
    Merlin, F.
    Lucenti, A.
    Valduga, F.
    Frisinghelli, M.
    Arisi, E.
    Galligioni, E.
    ANNALS OF ONCOLOGY, 2005, 16 : 80 - 80
  • [7] GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
    A. González Martín
    A. Redondo
    M. Jurado
    A. De Juan
    I. Romero
    I. Bover
    J. M. Del Campo
    A. Cervantes
    Y. García
    J. A. López-Guerrero
    C. Mendiola
    J. Palacios
    M. J. Rubio
    A. Poveda Velasco
    Clinical and Translational Oncology, 2013, 15 : 509 - 525
  • [8] GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
    Gonzalez Martin, A.
    Redondo, A.
    Jurado, M.
    De Juan, A.
    Romero, I.
    Bover, I.
    Del Campo, J. M.
    Cervantes, A.
    Garcia, Y.
    Lopez-Guerrero, J. A.
    Mendiola, C.
    Palacios, J.
    Rubio, M. J.
    Poveda Velasco, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (07): : 509 - 525
  • [9] Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: A gynecologic group study
    Fracasso, PM
    Blessing, JA
    Morgan, MA
    Sood, AK
    Hoffman, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2856 - 2859
  • [10] Phase II study of gemcitabine and vinorebline in patients with persistent or recurrent platinum-resistant ovarian or primary peritoneal cancer: A study of the Korean Cancer Study Group.
    Hong, Sook Hee
    Byun, Jae Ho
    Lee, Soohyeon
    Kim, Hoon-Gu
    Lee, Hyo Jin
    Jung, Kyung Hae
    Lee, Sang-Cheol
    Lee, Na-Ri
    Yun, Jina
    Hong, Dae-Sik
    Woo, In Sook
    Park, Kyong Hwa
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345